Related Experiment Video
Updated: Jan 30, 2026

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Manganese Enhanced MRI for Use in Studying Neurodegenerative Diseases
1Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, Bethesda, MD, United States.
Abstract:
MRI has been extensively used in neurodegenerative disorders, such as Alzheimer's disease (AD), frontal-temporal dementia (FTD), mild cognitive impairment (MCI), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). MRI is important for monitoring the neurodegenerative components in other diseases such as epilepsy, stroke and multiple sclerosis (MS). Manganese enhanced MRI (MEMRI) has been used in many preclinical studies to image anatomy and cytoarchitecture, to obtain functional information in areas of the brain and to study neuronal connections. This is due to Mn2+ ability to enter excitable cells through voltage gated calcium channels and be actively transported in an anterograde manner along axons and across synapses. The broad range of information obtained from MEMRI has led to the use of Mn2+ in many animal models of neurodegeneration which has supplied important insight into brain degeneration in preclinical studies. Here we provide a brief review of MEMRI use in neurodegenerative diseases and in diseases with neurodegenerative components in animal studies and discuss the potential translation of MEMRI to clinical use in the future.
Insights
Manganese-enhanced MRI (MEMRI) offers valuable insights into neurodegenerative diseases like Alzheimer's by visualizing neuronal connections and brain degeneration in preclinical studies. Future clinical applications are being explored.
Area of Science:
- Neuroimaging
- Neuroscience
- Biomedical Engineering
Background:
- Magnetic Resonance Imaging (MRI) is crucial for studying neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).
- Manganese-enhanced MRI (MEMRI) utilizes the unique properties of manganese (Mn2+) to visualize neuronal structures and function.
- Mn2+ enters excitable cells via voltage-gated calcium channels and is transported along axons, enabling detailed imaging of neural pathways.
Purpose of the Study:
- To review the application of MEMRI in preclinical studies of neurodegenerative diseases.
- To highlight MEMRI's utility in understanding brain degeneration and neuronal connectivity.
- To discuss the potential for translating MEMRI techniques to clinical settings.
Main Methods:
- Review of existing preclinical studies employing MEMRI in animal models of neurodegeneration.
- Analysis of Mn2+ properties enabling imaging of cellular anatomy, cytoarchitecture, and functional information.
- Examination of anterograde axonal transport and synaptic activity visualized by MEMRI.
Main Results:
- MEMRI provides detailed anatomical and functional information in various neurodegenerative disease models.
- Studies using MEMRI have yielded significant insights into brain degeneration processes.
- The technique has been instrumental in mapping neuronal connections and assessing neurodegeneration in preclinical research.
Conclusions:
- MEMRI is a powerful tool for investigating neurodegenerative diseases in animal models.
- Its ability to trace neuronal pathways and assess cellular function offers unique advantages.
- Further research may facilitate the clinical translation of MEMRI for diagnosing and monitoring human neurodegenerative conditions.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

